Zuvog Trio 2 Tablet SR: A Combination Therapy for Diabetes Management

Zuvog Trio 2 Tablet SR is a once-daily combination therapy designed to help manage type 2 diabetes. This fixed-dose tablet combines three powerful ingredients: Glimepiride (2mg), Metformin (500mg), and Voglibose (0.2mg).

Glimepiride: A sulfonylurea that stimulates insulin secretion from the pancreas, helping to lower blood sugar levels.
Metformin: An antihyperglycemic medication that helps reduce glucose production in the liver and increases insulin sensitivity.
Voglibose: A selective α-glucosidase inhibitor that slows down glucose absorption from the intestine, further regulating blood sugar.

Zuvog Trio 2 Tablet SR offers a convenient and consistent way to manage type 2 diabetes by effectively targeting multiple pathways for blood sugar regulation. It's important to remember that this medication is prescribed for individuals with type 2 diabetes under the supervision of a healthcare professional.

Please consult your doctor or pharmacist before taking any new medications.